Starting a GLP-1 medication like semaglutide or tirzepatide? Dr. Jamie Lewis and Becca Pabona, RN tackle the seven questions patients ask most — from side effects and "Ozempic face" to hair loss, fatigue, food noise, and what really happens when you stop. They break down the actual clinical trial data, explain why individualized microdosing produces better outcomes than one-size-fits-all protocols, and share the strategies their clinic uses to preserve muscle, prevent nutrient deficiencies, and build a foundation that lasts beyond the medication. Backed by 20 peer-reviewed references including data from the STEP trials, ENDO 2025, and the largest real-world GLP-1 cohort studies to date.